Using Lilly’s Taltz (ixekizumab) and Zepbound (tirazeptide) together found superior efficacy in a first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight – Eli Lilly & more related News Here
Using Lilly’s Taltz (ixekizumab) and Zepbound (tirazepide) together showed improved efficacy in a first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight.Eli Lilly Eli Lilly’s Zepbound, on top of immunology drug, helps reduce psoriatic arthritis symptomsstatnews.com Lilly promises Zepbound-Taltz combo for obesity and psoriatic arthritis patientsterrible pharma Lilly trial finds…
